Clinical trial webinar

If you're interested in clinical trial design trends, be sure to sign up for our online webinar tomorrow at 1 p.m. EST. We have around 550 people registered for the webinar, which features the thoughts of Tufts' Kenneth Katin, PricewaterhouseCoopers' Neil Patel and Ray Woosley from the Critical Path Institute. I'd like to thank our sponsor, Insightful, for making it happen. - John Carroll

Suggested Articles

Xcovery's ALK inhibitor shrank tumors in 75% of lung cancer patients, compared to 67% for Pfizer's Xalkori, the first FDA-approved drug of that class.

The FDA accepted the regulatory filing for Biogen's once-failed Alzheimer's drug, aducanumab, with plans to decide its fate by March 7, 2021.

Alexion named a chief diversity officer, while COVID-19 vaccine player has two new members of its C-suite.